logo

Katherine Matthay, MD

Katherine Matthay, MD

Hematology San Francisco, CA

Professor of Pediatrics, UCSF

Office Address

Office Map
  • 505 Parnassus Ave
    San Francisco, CA 94143
    Phone: (415) 476-3831
    Fax: (415) 502-4372

Dr. Matthay's Clinical Specialties & Interests

  • Hematology: General Hematology

Dr. Matthay's Education & Medical Training

  • University of California at San FranciscoUniversity of California at San FranciscoFellowship, Pediatric Hematology/Oncology
  • University of ColoradoUniversity of ColoradoResidency, Pediatrics
  • U Penn Med SchoolPerelman School of Medicine at the University of PennsylvaniaMedical School

Dr. Matthay's Certifications & Licensure

  • CA State Medical LicenseCA State Medical License1977 - 2015
  • American Board of PediatricsAmerican Board of PediatricsPediatrics
  • American Board of PediatricsAmerican Board of PediatricsPediatric Hematology-Oncology

Dr. Matthay's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com

Dr. Matthay's Clinical Trials

Dr. Matthay's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Pediatric Malignancies Program
    Pediatric Malignancies ProgramNational Cancer Institute
    2007 - 2011
  • Impact Of Body Composition On PK Of Doxorubin In Pediatric Patients
    Impact Of Body Composition On PK Of Doxorubin In Pediatric PatientsNational Center For Research Resources
    2005 - 2005
  • NANT 2003-01: Phase I Study Of Oral Irinotecan, Temozolomide, And Cefixime
    NANT 2003-01: Phase I Study Of Oral Irinotecan, Temozolomide, And CefiximeNational Center For Research Resources
    2005 - 2005
  • Anbl02p1: A Pilot Induction Regimen Incorporating Topotecan For Neuroblastoma
    Anbl02p1: A Pilot Induction Regimen Incorporating Topotecan For NeuroblastomaNational Center For Research Resources
    2005 - 2005
  • NANT #9902: Modulation Of L-PAM By BSO With Autologous Stem Cell Support
    NANT #9902: Modulation Of L-PAM By BSO With Autologous Stem Cell SupportNational Center For Research Resources
    2005 - 2005
  • Dose Escalation Study Of 131 I-MIBG With Chemotherapy And Stem Cell Rescue
    Dose Escalation Study Of 131 I-MIBG With Chemotherapy And Stem Cell RescueNational Center For Research Resources
    2005 - 2005
  • Impact Of Body Composition On PK Of Doxorubicin In Ped
    Impact Of Body Composition On PK Of Doxorubicin In PedNational Center For Research Resources
    2004 - 2004
  • NANT 2001-01:A Phase I Investigation Of Il-12/Pulse IL-2 In Children
    NANT 2001-01:A Phase I Investigation Of Il-12/Pulse IL-2 In ChildrenNational Center For Research Resources
    2004 - 2005
  • NANT 2001-03: Phase I Study Of CEP-701 In Patients With Refractory Neuroblastoma
    NANT 2001-03: Phase I Study Of CEP-701 In Patients With Refractory NeuroblastomaNational Center For Research Resources
    2004 - 2005
  • Advl0116: A Phase I Trial And PK Study Of R115777 In Pediatric Patients
    Advl0116: A Phase I Trial And PK Study Of R115777 In Pediatric PatientsNational Center For Research Resources
    2004 - 2004
  • 131 I-MIBG Escalating Dose Rapid Sequence Double Infusi*
    131 I-MIBG Escalating Dose Rapid Sequence Double Infusi*National Cancer Institute
    2004 - 2004
  • Phase I Intergroup Trial Of Hu14.18-Il.2 Fusion Protein In Children
    Phase I Intergroup Trial Of Hu14.18-Il.2 Fusion Protein In ChildrenNational Center For Research Resources
    2004 - 2004
  • 131 I-Labeled MIBG For Treatment Of Advanced Neuroblastoma: A Phase II Study
    131 I-Labeled MIBG For Treatment Of Advanced Neuroblastoma: A Phase II StudyNational Center For Research Resources
    2004 - 2005
  • 131 I-MIBG Double Infusion Followed By Stem Cells For Refractory Neuroblastoma
    131 I-MIBG Double Infusion Followed By Stem Cells For Refractory NeuroblastomaNational Center For Research Resources
    2004 - 2005
  • Nant2002-01: A Phase I Study Of High Dose Pyrazoloacridine
    Nant2002-01: A Phase I Study Of High Dose PyrazoloacridineNational Center For Research Resources
    2004 - 2004
  • 131imibg Escalating Dose Rapid Sequence Double Infusion
    131imibg Escalating Dose Rapid Sequence Double InfusionNational Cancer Institute
    2003 - 2003
  • Clinical Therapy Trials
    Clinical Therapy TrialsNational Cancer Institute
    2000 - 2011
  • Paclitaxel In Refractory Leukemia In Children
    Paclitaxel In Refractory Leukemia In ChildrenNational Center For Research Resources
    2000 - 2000
  • CCG 0954: Gemcitabine In Solid Tumors
    CCG 0954: Gemcitabine In Solid TumorsNational Center For Research Resources
    2000 - 2002
  • CCG 09709: Fenretinide In Children W/ High Risk Solid Tumors
    CCG 09709: Fenretinide In Children W/ High Risk Solid TumorsNational Center For Research Resources
    2000 - 2002
  • Thrombopoietin &G-Csf In Child Solid Tumors
    Thrombopoietin &G-Csf In Child Solid TumorsNational Center For Research Resources
    2000 - 2000
  • Phase I Study Of Continuous 21 Day Topotecan In Children With Relapsed Tumors
    Phase I Study Of Continuous 21 Day Topotecan In Children With Relapsed TumorsNational Center For Research Resources
    1998 - 2002
  • Pediatric Trial And PK Study Of Lgd1057
    Pediatric Trial And PK Study Of Lgd1057National Center For Research Resources
    1998 - 2002
  • Phase I Study Of Topotecan And Cisplatin In Solid Tumors In Children
    Phase I Study Of Topotecan And Cisplatin In Solid Tumors In ChildrenNational Center For Research Resources
    1998 - 1999
  • Phase I Study Of Anti B4 Blocked Ricin In Children With Leukemia Or Lymphoma
    Phase I Study Of Anti B4 Blocked Ricin In Children With Leukemia Or LymphomaNational Center For Research Resources
    1998 - 2002
  • Phase I Study Of Topotecan And Field Radiation For Pontine Glioma Of Childhood
    Phase I Study Of Topotecan And Field Radiation For Pontine Glioma Of ChildhoodNational Center For Research Resources
    1998 - 1999
  • Phase I Study Of D1694 In Pediatric Patients With Advanced Neoplastic Disease
    Phase I Study Of D1694 In Pediatric Patients With Advanced Neoplastic DiseaseNational Center For Research Resources
    1998 - 2002
  • Phase I Study Of Gamma Interferon Transduced Neuroblastoma Cells
    Phase I Study Of Gamma Interferon Transduced Neuroblastoma CellsNational Center For Research Resources
    1998 - 2002
  • IL 6 PLUS G-CSF Following ICE In Children With Recurrent Solid Tumors
    IL 6 PLUS G-CSF Following ICE In Children With Recurrent Solid TumorsNational Center For Research Resources
    1998 - 1999
  • B43-PAP Immunotoxin With 4 Drug Induction For All In Relapse
    B43-PAP Immunotoxin With 4 Drug Induction For All In RelapseNational Center For Research Resources
    1998 - 2002
  • Trial Of Temozolomide In Children And Adolescents With Progressive Cancer
    Trial Of Temozolomide In Children And Adolescents With Progressive CancerNational Center For Research Resources
    1998 - 2002
  • CI Mercaptopurine Followed By CI ARA-C In Children
    CI Mercaptopurine Followed By CI ARA-C In ChildrenNational Center For Research Resources
    1998 - 2002
  • Phase I Multiple Cycles Of High Dose Chemotherapy With Stem Cell Transfusions
    Phase I Multiple Cycles Of High Dose Chemotherapy With Stem Cell TransfusionsNational Center For Research Resources
    1998 - 1999
  • Pilot Study Of Buthionine Sulfoximine In Combination With Melphalan
    Pilot Study Of Buthionine Sulfoximine In Combination With MelphalanNational Center For Research Resources
    1997 - 2002
  • I-131 MIBG Therapy For Neuroblastoma
    I-131 MIBG Therapy For NeuroblastomaNational Center For Research Resources
    1997 - 2002
  • Phase I Study Of Taxol In Refractory Leukemia In Children
    Phase I Study Of Taxol In Refractory Leukemia In ChildrenNational Center For Research Resources
    1997 - 1997
  • Phase I Chimeric Human/Murine Anti-Gd2 Monoclonal Antibody With GM-CSF
    Phase I Chimeric Human/Murine Anti-Gd2 Monoclonal Antibody With GM-CSFNational Center For Research Resources
    1996 - 2002
  • Phase I Study Of Taxotere In Pediatric Patients With Advanced Neoplastic Disease
    Phase I Study Of Taxotere In Pediatric Patients With Advanced Neoplastic DiseaseNational Center For Research Resources
    1996 - 2002
  • Phase I Trial Of Temozolomide In Children &Adolescents With Progressive Cancer
    Phase I Trial Of Temozolomide In Children &Adolescents With Progressive CancerNational Center For Research Resources
    1996 - 1996
  • Phase I Trial Of All-Trans Retinoic Acid In Combination With Interferon
    Phase I Trial Of All-Trans Retinoic Acid In Combination With InterferonNational Center For Research Resources
    1995 - 1995
  • I-131 MIBG For Treatment Of Advanced Neuroblastoma
    I-131 MIBG For Treatment Of Advanced NeuroblastomaNational Center For Research Resources
    1995 - 1996
  • Treatment Of Newly Diagnosed Acute Lymphoblastic Leukemia In Children
    Treatment Of Newly Diagnosed Acute Lymphoblastic Leukemia In ChildrenNational Center For Research Resources
    1995 - 1995
  • Chemotherapy VS Autologous Bone Marrow Transplant For High Risk Neuroblastoma
    Chemotherapy VS Autologous Bone Marrow Transplant For High Risk NeuroblastomaNational Center For Research Resources
    1995 - 1995
  • Phase I Evaluation Of Oral/Intravenous Navelbine In Pediatric Cancer Patients
    Phase I Evaluation Of Oral/Intravenous Navelbine In Pediatric Cancer PatientsNational Center For Research Resources
    1995 - 1995
  • Childrens Cancer Group
    Childrens Cancer GroupNational Cancer Institute
    1994 - 2002
  • Children'S Cancer Study Group
    Children'S Cancer Study GroupNational Cancer Institute
    1993 - 1993
  • Treatment Of Leukemia By Antibody-Directed Liposomes
    Treatment Of Leukemia By Antibody-Directed LiposomesNational Cancer Institute
    1989 - 1991
  • Treatment Of Bone Marrow By Antibody-Directed Liposomes
    Treatment Of Bone Marrow By Antibody-Directed LiposomesNational Cancer Institute
    1985 - 1987

Dr. Matthay's Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PPO
  • Blue Shield California HMO
  • Blue Shield California PPO
  • First Health PPO
  • Health Net California Large Group PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • Pacificare HMO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Katherine Matthay, Dr. Katherine Matthay, MD, Dr. K Matthay, Dr. Katherine K. Matthay

20 Colleague Invites!
Is this you? If so, register to see 20 messages.

Physicians, view Dr. Matthay's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV